Maselli D, Atieh J, Clark MM, Eckert D, Taylor A, Carlson P, et al
The environmental pressure created by SPPS's solvent intensity at GLP-1 commercial volumes has accelerated interest in solvent recycling systems, aqueous synthesis approaches, and fully enzymatic oligonucleotide synthesis platforms whose principles are being explored for potential peptide applications
Remember that diabetes management is a partnership between you and your healthcare team, and open communication about treatment effectiveness is crucial for achieving the best possible outcomes
Several companies that had initially set annual sales estimates of 100-150 crore from their GLP-1 portfolios are bracing for a 25-30% downward revision, amid sluggish adoption by physicians, price competition with innovator molecules, patient drop-offs, and device-related complexity